Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Benefits of Hexarelin An increasingly popular conversation around hexarelin is its potential use to improve body composition
Market Overview and Size Global Market Growth The obesity drugs market was valued at $20.20 billion in 2024 and is projected to reach $86.71 billion by 2030 , growing at a robust 27.5% CAGR
All peptides referenced are intended strictly for laboratory research use and are not approved for human consumption, diagnosis, or treatment of any medical condition
Standard care begins with 3 months of GLP-1 injections, with dosage adjustments and monitoring via regular check-ins
In clinical trials, patients on Tirzepatide lost up to 21% of body weight, compared to around 15% on Semaglutide, making it an attractive option for patients seeking more aggressive weight loss
